The US Anti-Doping Agency (ADA) states that because it has not been extensively studied in humans, "no-one knows if there is a safe dose, or if there is any way to use this compound safely to treat specific medical conditions"
Reported benefits (per available research): Studied for its ability to produce sustained, dose-dependent increases in growth hormone and IGF-1 secretion in a Phase 1 human trial in healthy adults, published by Teichman et al
Over time, you may not experience any side effects at all with the shots.
But if you have a medically diagnosed deficiency, you can get these injections for free through the NHS
While public statements do not instantly change federal law, this potential regulatory shift has sparked widespread excitement about the future of physician-led peptide therapies
Hierarchy of Evidence: Level D (In vitro and rodent models)